Donate to Brain Cancer Research |The Lundin Group

Lukas H. Lundin
1958-2022
Lukas died at the age of 64 from glioblastoma, a form of brain cancer.

A man who made a difference in this world. Let’s continue the journey.

Lukas’ life journey was a remarkable one. Entrepreneurial, and always adventurous, he was passionate about the resource industry and its power to transform lives. From the high Andes of Argentina to the jungles of Ecuador, he pursued opportunities that led to some of the largest and most successful resource developments in the world.

His last major initiative was the establishment of the Lundin Family Brain Tumour Research Centre.

Let’s build upon his legacy.

See a map of Lukas Lundin's remarkable journey

Lundin Family Brain Tumour Research Centre
CHUV University Hospital at Lausanne, Switzerland

Funding the very best in brain cancer research

There is a significant lack of funding and awareness about brain cancer. Lukas’ sons, Adam, Jack, William and Harry Lundin, want to honour their father by helping to fund cutting edge research at CHUV, one of the top cancer research hospitals in the world, ultimately allowing for more widely available and effective treatment options. The Lundin family is committed to funding brain cancer research at CHUV over the long term. The work at CHUV is collaborative and any wins in research are shared with hospitals worldwide, allowing exponential growth in those benefits to so many more.

Please join us on this journey to push the boundaries of cancer research innovation.

Download our brochure Learn more about CHUV Hospital

Newsletter 2023 No. 1

What Is Glioblastoma?

A rare but very aggressive
brain tumour
No known risk factors
Resistant to treatment

How Will the Funds Raised be Used

Expansion

Expanding the Brain & Spine Tumour Centre activity from preclinical to clinical research

Clinical Trials

Clinical trials represent an important opportunity for patients to benefit from the latest advances in the field

Innovation

Push innovation boundaries in Neuro-Oncology

Neuro-Oncology Research Platform

Network of centres to coordinate treatment schemes, foster exchange of ideas between clinicians and biologists, provide cutting edge translational and clinical research and promote individualized therapy for brain cancer patients

Collaboration

Local and international collaborations in neuro-oncology

Research

Push the boundaries of knowledge and accelerate the development of solutions

Top Three Clinical Trial Projects

Engineering T cell therapies
Disrupting the blood brain barrier (BBB) to treat brain tumours
Launching a clinical trial platform

Lundin Family Committed to Funding Brain Cancer Research Over the Long Term

Lukas’ sons, Jack, William, Adam and Harry, would like to work with his friends and colleagues to build upon and carry forward this important legacy.

The CHUV funding initiative and climbing Mount Everest to raise awareness of brain cancer are all in honour of their dad.

Lukas’ life journey was a truly remarkable one.

We want to honour Lukas by helping to fund cutting edge research at one of the top cancer research hospitals in the world, ultimately allowing for more widely available and effective treatment options around the world.

Our goal is to make a high impact investment in brain cancer research that significantly benefits patients and for them to know that they are not alone in their fight.

Please join us on this journey.

The Lundin Family are committed to raising awareness and funding to help advance brain cancer research in a meaningful way.

By donating to the Lundin Family Brain Tumour Research Center, you are helping to carry on Lukas’ legacy and push the boundaries of brain cancer research.

Donate Today

Thank you. We appreciate your support.

For more information contact us or download the Lundin Family Brain Tumour Research Centre Booklet

Download Booklet